InventisBio (SH:688382) Xin Lang Cai Jing·2025-10-16 02:16Group 1 - Yifang Biotechnology's stock increased by 5.25%, reaching a price of 28.25 CNY per share, with a trading volume of 204 million CNY and a turnover rate of 1.75%, resulting in a total market capitalization of 16.338 billion CNY [1] - Yifang Biotechnology (Shanghai) Co., Ltd. was established on January 11, 2013, and went public on July 25, 2022. The company focuses on the research, production, and sales of innovative drugs, with its main revenue source being technology licensing and cooperation, accounting for 100% of its revenue [1] Group 2 - According to data, the Tongtai Health Theme Mixed A Fund (011002) holds a significant position in Yifang Biotechnology, with 37,200 shares, representing 5.42% of the fund's net value, making it the fourth-largest holding [2] - The Tongtai Health Theme Mixed A Fund was established on April 8, 2021, with a latest scale of 6.1823 million CNY. Year-to-date returns are 29.83%, ranking 2955 out of 8161 in its category, while the one-year return is 22.6%, ranking 4191 out of 8021 [2] - The fund manager, Ma Yi, has a tenure of 11 years and 214 days, managing assets totaling 6.063 billion CNY, with the best return during his tenure being 40.95% and the worst being -0.63% [2] - Co-manager Mai Jianpei has a tenure of 158 days, managing assets of 161 million CNY, with the best return during his tenure being 22.24% and the worst being -2.2% [2]